Guideline document

Your browser can't display PDFs inline. Open the guideline in a new tab.

This guideline is provided for in-page reading only. Please contact the publishing organization for downloadable copies.

1 Views
0 Likes
0 Shares
0 Comments

StayCurrentMD

View profile →

Clinical Guideline

Non-Hodgkin Lymphoma PDQ®

Topic overview

NCI's evidence-based clinical reference for healthcare professionals managing childhood non-Hodgkin lymphoma. Provides comprehensive treatment protocols, risk stratification, and therapeutic approaches for pediatric lymphoid malignancies including B-cell and T-cell subtypes.

Key Takeaways

  • Childhood non-Hodgkin lymphoma requires different treatment approaches than adult NHL due to distinct biology and histology.
  • Aggressive chemotherapy regimens are standard, with treatment intensity based on stage and histologic subtype.
  • CNS prophylaxis is critical in high-risk subtypes like lymphoblastic lymphoma and Burkitt lymphoma.
  • Prognosis varies significantly by subtype: Burkitt and lymphoblastic lymphomas have cure rates exceeding 80% with modern therapy.
  • Multidisciplinary care including pediatric oncology, surgery, and radiation oncology optimizes outcomes.

Keywords

Pediatric Oncology Non-hodgkin Lymphoma Childhood Cancer Lymphoma Treatment Hematologic Malignancy Pdq Clinical Reference

Hashtags

#PediatricOncology #ChildhoodCancer #NonHodgkinLymphoma #HematologyOncology

Full guideline text

Full text not available for this guideline
How to cite: GlobalCastMD. Non-Hodgkin Lymphoma PDQ®. GlobalCastMD Medical Library. https://library.globalcastmd.com/guideline/2380

Comments

Loading comments...